108 related articles for article (PubMed ID: 9316284)
1. Does vancomycine increase aminoglycoside nephrotoxicity?
Törel Ergür A; Onarlioglu B; Günay Y; Cetinkaya O; Eray Bulut H
Acta Paediatr Jpn; 1997 Aug; 39(4):422-7. PubMed ID: 9316284
[TBL] [Abstract][Full Text] [Related]
2. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin.
Bonadio M; Maccanti O; Giovannini L; Bertelli AA; Scalori V; Alessandrì MG; Bertelli A
Drugs Exp Clin Res; 1987; 13(12):747-50. PubMed ID: 3447878
[TBL] [Abstract][Full Text] [Related]
3. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E
Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910
[TBL] [Abstract][Full Text] [Related]
4. Comparative nephrotoxicity of hydroxygentamicin and other aminoglycosides in rats.
Slighter RG; Montenaro MJ; Fabian RJ; Bhandari JC; Donikian MR; Drobeck HP
Fundam Appl Toxicol; 1984 Aug; 4(4):558-67. PubMed ID: 6479501
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats.
Parlakpinar H; Koc M; Polat A; Vardi N; Ozer MK; Turkoz Y; Acet A
Urol Res; 2004 Aug; 32(4):278-82. PubMed ID: 15278326
[TBL] [Abstract][Full Text] [Related]
6. The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity.
Asci H; Saygin M; Cankara FN; Bayram D; Yesilot S; Candan IA; Ilhan I
Ren Fail; 2015 Feb; 37(1):117-21. PubMed ID: 25296102
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
Inouye S; Niizato T; Shomura T; Kitasato I
Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of enzymuria, in the rat, of the drug combinations amikacin/vancomycin and amikacin/teicoplanin.
Fauconneau B; Pariat C; Bouquet S; Piriou A; Ingrand P; Courtois P
Ren Fail; 1993; 15(4):469-73. PubMed ID: 8105516
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Goren MP; Baker DK; Shenep JL
Pediatr Infect Dis J; 1989 May; 8(5):278-82. PubMed ID: 2657616
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A
Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879
[TBL] [Abstract][Full Text] [Related]
11. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
Fillastre JP; Hemet J; Tulkens P; Morin JP; Viotte G; Olier B; Godin M
Adv Nephrol Necker Hosp; 1983; 12():253-75. PubMed ID: 6404138
[TBL] [Abstract][Full Text] [Related]
12. Amikacin nephrotoxicity in the rat.
Houghton DC; Plamp CE; Gilbert DN; Kohlhepp SJ; Bennett WM; Porter GA; DeFehr J; Webb M
J Environ Pathol Toxicol; 1980 Nov; 4(5-6):277-91. PubMed ID: 7217852
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of dexpanthenol against nephrotoxic effect of amikacin: An experimental study.
Doğan EE; Erkoç R; Ekinci İ; Hamdard J; Döner B; Çıkrıkçıoğlu MA; Karatoprak C; Çoban G; Özer ÖF; Kazancıoğlu R
Biomed Pharmacother; 2017 May; 89():1409-1414. PubMed ID: 28320109
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
15. Role of erythropoietin in prevention of amikacin-induced nephropathy.
Kaynar K; Aliyazioglu R; Ersoz S; Ulusoy S; Al S; Ozkan G; Cansiz M
J Nephrol; 2012; 25(5):744-9. PubMed ID: 22322815
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of aminoglycosides in young and adult rats.
Provoost AP; Adejuyigbe O; Wolff ED
Pediatr Res; 1985 Nov; 19(11):1191-6. PubMed ID: 4069829
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
Gatell JM; San Miguel JG; Zamora L; Araujo V; Bonet M; Bohé M; Jimenez de Anta MT; Farré M; Elena M; Ballesta A; Marin JL
Antimicrob Agents Chemother; 1983 Jun; 23(6):897-901. PubMed ID: 6614894
[TBL] [Abstract][Full Text] [Related]
18. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
19. Distribution of epidermal growth factor in the kidneys of rats exposed to amikacin.
Toubeau G; Nonclercq D; Zanen J; Lambricht P; Tulkens PM; Heuson-Stiennon JA; Laurent G
Kidney Int; 1991 Oct; 40(4):691-9. PubMed ID: 1745019
[TBL] [Abstract][Full Text] [Related]
20. The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
Madbouly N; Azmy A; Salama A; El-Amir A
J Antibiot (Tokyo); 2021 Sep; 74(9):580-592. PubMed ID: 34253885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
